Literature DB >> 10090294

Circadian variation in blood pressure: implications for the elderly patient.

W J Elliott1.   

Abstract

In most people, blood pressure (BP) displays a characteristic diurnal pattern, with a decline during sleep and a sharp increase around the time of awakening. The early morning surge in BP is synchronous with an increase in the risk of catastrophic cardiovascular events, including acute myocardial infarction, sudden cardiac death, and stroke. Although most clinical investigations have centered on modulating or even preventing the morning surge, emerging data suggest that it may be important to avoid nocturnal hypotension, especially in elderly patients and in those with established atherosclerotic disease. Considerable evidence has been accumulated to suggest that excessive lowering of BP at night (whether naturally or through the use of antihypertensive medications) can result in untoward ischemic phenomena, including silent cerebral damage (Binswanger's disease) or ophthalmologic symptoms (eg, anterior ischemic optic neuropathy). Controlled-onset extended-release verapamil, through its unique delivery system, tends to diminish the morning BP surge, whereas it preserves a normal nocturnal BP decline; its effect on preventing early morning cardiovascular catastrophes (while preserving relatively normal nocturnal BP) is currently being tested in a large, international clinical trial.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10090294     DOI: 10.1016/s0895-7061(98)00279-9

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  9 in total

Review 1.  Hypertension in patients presenting with stroke.

Authors:  B J Pearson; P M Bath; J D Spence
Journal:  Curr Hypertens Rep       Date:  2000-12       Impact factor: 5.369

2.  Systolic blood pressure and six-year mortality in South Africa: Evidence from a country-wide population-based cohort study.

Authors:  Alpha Oumar Diallo; Mohammed K Ali; Pascal Geldsetzer; Emily W Gower; Trasias Mukama; Ryan G Wagner; Justine Davies; Maarten J Bijlsma; Nikkil Sudharsanan
Journal:  Lancet Healthy Longev       Date:  2021-01-18

Review 3.  Olmesartan vs. ramipril in elderly hypertensive patients: review of data from two published randomized, double-blind studies.

Authors:  Stefano Omboni; Ettore Malacco; Jean-Michel Mallion; Paolo Fabrizzi; Massimo Volpe
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-01-17

Review 4.  Drug interactions with angiotensin receptor blockers: a comparison with other antihypertensives.

Authors:  Thomas Unger; Elena Kaschina
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

5.  Time course for blood pressure lowering of beta-blockers with partial agonist activity.

Authors:  Xiao-Yin Zhang; Sam Soufi; Colin Dormuth; Vijaya M Musini
Journal:  Cochrane Database Syst Rev       Date:  2020-09-05

Review 6.  COVID-19: Sleep, Circadian Rhythms and Immunity - Repurposing Drugs and Chronotherapeutics for SARS-CoV-2.

Authors:  Allan Giri; Ashokkumar Srinivasan; Isaac Kirubakaran Sundar
Journal:  Front Neurosci       Date:  2021-06-18       Impact factor: 4.677

7.  Diurnal Variation of Retinal Vessel Density in Healthy Human Eyes.

Authors:  Jo-Hsuan Wu; Rafaella C Penteado; Sasan Moghimi; Linda M Zangwill; James A Proudfoot; Robert N Weinreb
Journal:  J Glaucoma       Date:  2021-09-01       Impact factor: 2.290

8.  Associations of time of day with cardiovascular disease risk factors measured in older men: results from the British Regional Heart Study.

Authors:  Claudio Sartini; Peter H Whincup; S Goya Wannamethee; Barbara J Jefferis; Lucy Lennon; Gordon DO Lowe; Paul Welsh; Naveed Sattar; Richard W Morris
Journal:  BMJ Open       Date:  2017-11-12       Impact factor: 2.692

9.  Evaluating the seasonal variations in the circulatory dynamics of community-dwelling older people while exercising outdoors in the early morning.

Authors:  Takuya Ueda; Yoshitaka Shiba; Shuichiro Watanabe
Journal:  J Phys Ther Sci       Date:  2020-02-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.